Cannabis Report
Home > Boards > US OTC > Biotechs >

Amarantus Bioscience Holdings Inc. (AMBS)

AMBS RSS Feed
Add AMBS Price Alert      Hide Sticky   Hide Intro
Moderator: JPetroInc, redspeed, zigzagman, budfoxhub, zoomboom, FollowTheProfits
Search This Board: 
Last Post: 6/17/2018 8:48:07 PM - Followers: 693 - Board type: Free - Posts Today: 10

 

(AMBS) Amarantus BioScience Holdings, Inc. 

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis.
The company has licensed Eltoprazine, a Phase 3 ready Parkinsons Levadopa induced Dyskinesia.

 (MANF) is a human growth factor that plays a key role in the prevention of apoptosis (cell death). It is being developed for the potential treatment of RP, Parkinson's disease, Wolfram syndrome, diabetes, Alzheimer's disease and traumatic brain injury.

ESS, previously known as PermaDerm®  is being developed to be the only tissue-engineered skin prepared from autologous (patient's own) skin cells consisting of both epidermal and dermal layers. A small harvested section of the patient's own skin can be grown to graft an area one hundred times its size in as little as thirty days. 
For further information, please visit www.Amarantus.com, or connect with the company in FacebookTwitter, LinkedIn & Google+
 
                                                                                       


 

NEWS



Bio-engineering skin to treat severe burns
 
 

   Videos

 

Gerald Commissiong, CEO of Amarantus BioScience Holdings, Inc. (OTCQX: AMBS) chats with Bob Power, OTC Markets VP of Corporate Services
Mar. 18, 2016

 
SNNLive with Amarantus Bioscience Holdings, Inc. (OTCQX: AMBS)  
December 2015


 

ESS Patients: Dr. Ahrenholz Interview Part 1 
 

ESS vs the Competition: Dr. Ahrenholz Interview Part 2

The Need for ESS: Dr. Ahrenholz Interview Part 3
 
 
 

 
                                                                                                                
 
 
    
       
 


                                                               Contact Information

Amarantus BioScience Holdings, Inc.
655 Montgomery Street
Suite 900
San Francisco, CA 94111

 

c/o ICS Corporate Services SA
29 quai du Mont Blanc
CH-1201 Geneva
Switzerland












 

info@amarantus.com
pr@amarantus.com


Phone: (415) 688-4484
Fax: (408) 852-4427


Gerald's email address
Gerald@amarantus.com



IR Calendar 






 

INVESTOR RELATIONS

Jenene Thomas Communications
Jenene Thomas
T: 908-938-1475

ir@amarantus.com


 

TRANSFER AGENT

VStock Transfer, LLC
Allison Niccols
77 Spruce Street
Suite 201
Cedarhurst, N 11516
T: 212-828-8436
F: 646-536-3179
info@vstocktransfer.com
www.VStockTransfer.com

 

 
 
                                                                            

 

Cannabis Report
AMBS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMBS News: MANF Therapeutics Announces Independent Publication of Positive Data for MANF in Traumatic Brain Injury Animal Model 06/11/2018 07:00:00 AM
AMBS News: Amarantus Provides Update on Elto Pharma Capital Formation Plan 06/07/2018 08:17:00 AM
AMBS News: MANF Therapeutics Announces Publication of Positive Data for MANF in Stroke Animal Model in AAAS Journal Science Advances 06/05/2018 08:11:00 AM
AMBS News: Amarantus Exercises Exclusive Option with Leipzig University for Alzheimer's Blood Diagnostic "LymPro Test 2.0" 05/30/2018 08:00:00 AM
AMBS News: Amarantus to Present at LD Micro and The Reg A Conference 05/24/2018 11:00:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#128357  Sticky Note what are you talking about? JPetroInc 06/16/18 01:00:07 PM
#127802  Sticky Note NEWS OUT FollowTheProfits 06/05/18 09:12:57 AM
#127238  Sticky Note Amarantus Completes Tender Exchange of Convertible Securities zoomboom 04/04/18 09:13:34 AM
#128385   we’re awash in shares JPetroInc 06/17/18 08:48:06 PM
#128384   No he didn't. Not that I think this freegriff 06/17/18 08:40:36 PM
#128383   The float is 100% at 205M. GC just GoClippers 06/17/18 08:33:19 PM
#128382   were well north of 150-Mil. JPetroInc 06/17/18 07:10:17 PM
#128381   Gerald just gifted his Dad 15 million shares SidVicious 06/17/18 04:35:59 PM
#128380   It was 75,956,228 back on 12/06/2017. What was redspeed 06/17/18 04:04:12 PM
#128379   touché - you’re the auditor of viewer count JPetroInc 06/17/18 11:41:54 AM
#128378   surprisingly so, you failed to answer the question JPetroInc 06/17/18 11:38:40 AM
#128377   I bet JP is glad the US didn't freegriff 06/17/18 10:05:13 AM
#128376   Five. I missed one. Zoom, FG, Sid, JP, redspeed 06/17/18 12:12:26 AM
#128375   I am pretty, pretty sure it's not 205M redspeed 06/16/18 11:36:53 PM
#128374   where are the metrics that show only 4 JPetroInc 06/16/18 11:34:36 PM
#128373   What’s the float Red JPetroInc 06/16/18 11:29:51 PM
#128372   You said the AMBS float was 205M. That's redspeed 06/16/18 11:09:12 PM
#128371   What's with the bold all the time? I redspeed 06/16/18 11:06:40 PM
#128370   Don’t assume anything JPetroInc 06/16/18 11:04:34 PM
#128369   Red the reality is if AMBS's assets were JPetroInc 06/16/18 10:57:39 PM
#128368   I thing 99% that have been invested in redspeed 06/16/18 07:10:20 PM
#128367   net present value emphasis on "present" freegriff 06/16/18 06:34:13 PM
#128366   that valuation is only if it works freegriff 06/16/18 06:31:38 PM
#128365   A phase II CNS asset at this stage redspeed 06/16/18 06:24:48 PM
#128364   it doesn’t flipping work yet JPetroInc 06/16/18 06:18:26 PM
#128363   You are going to be for a very redspeed 06/16/18 06:09:59 PM
#128362   that valuation is only if it works JPetroInc 06/16/18 04:46:10 PM
#128361   Do you remember what the company paid for Eltoprazine? redspeed 06/16/18 04:37:14 PM
#128360   excellent concern for the medically disadvantaged JPetroInc 06/16/18 03:45:06 PM
#128359   yeah, just like Gerald is "for real" JPetroInc 06/16/18 01:04:00 PM
#128358   we do talk about AMBS’s progress here JPetroInc 06/16/18 01:01:40 PM
#128357   what are you talking about? JPetroInc 06/16/18 01:00:07 PM
#128356   o/s was 205 on june 1 freegriff 06/16/18 11:13:18 AM
#128355   One thing said the deal with the lenders redspeed 06/16/18 10:59:06 AM
#128354   Uh huh. This time the promises are for SidVicious 06/16/18 09:55:14 AM
#128353   Lot of shares getting bought. Over a million redspeed 06/16/18 09:38:54 AM
#128352   But Spence is in charge. redspeed 06/16/18 09:37:14 AM
#128351   I wonder who's selling all their $AMBS shares? HHMMMM? SidVicious 06/16/18 08:45:33 AM
#128349   those that continue not want to talk about redspeed 06/16/18 01:56:12 AM
#128348   those that continue do Gerald’s bidding JPetroInc 06/16/18 01:29:44 AM
#128347   I wonder who is buying so many $ABMS redspeed 06/16/18 01:05:23 AM
#128346   But, but who is buying $AMBS? Could you redspeed 06/16/18 01:04:21 AM
#128345   Hmmm, I wonder who is selling so many SidVicious 06/16/18 12:58:24 AM
#128344   Come on now. Be nice. Lot of shares redspeed 06/15/18 10:22:37 PM
#128342   spooky stuff freegriff 06/15/18 08:16:13 PM
#128341   Everyday a million $AMBS shares get gobbled up redspeed 06/15/18 08:13:58 PM
#128340   AMBS treasury JPetroInc 06/15/18 07:46:44 PM
#128339   Wondering who is adding so many AMBS shares. zoomboom 06/15/18 07:36:10 PM
#128338   Where did that come from? Are there AMBS redspeed 06/15/18 07:01:10 PM
#128337   $AMBS up over 8% today on over 1M shares. redspeed 06/15/18 05:18:33 PM
#128336   So what you are really writing is the SidVicious 06/15/18 04:41:37 PM
#128335   Many times and for many reasons MM’s can zoomboom 06/15/18 02:31:35 PM
#128334   22 to 1 sell to buy ratio today. 7Bullet7 06/15/18 02:06:03 PM
PostSubject